The structure of XIAP BIR2: understanding the selectivity of the BIR domains
Autor: | Andreas Kuglstatter, Shirley Li, Robert Crowther, Christine Lukacs, Cheryl Janson, Srinivasan Swaminathan, Stacy Remiszewski, Manish Kumar Thakur, Andrew Schutt, Rajat Pandey, Waleed Danho, Barry Goggin, Rajiv Tyagi, Saroj K. Singh, Charles Belunis, Ramachandraiah Gosu, Lin Gao, Ajith V. Kamath |
---|---|
Rok vydání: | 2013 |
Předmět: |
Molecular Sequence Data
AVPI Regulator Apoptosis X-Linked Inhibitor of Apoptosis Protein Caspase 3 Crystallography X-Ray Inhibitor of apoptosis Inhibitor of Apoptosis Proteins Viral Proteins XIAP Structural Biology Protein Interaction Mapping Humans Amino Acid Sequence Peptide sequence Caspase Oligopeptide biology BIR domains General Medicine Research Papers Caspase Inhibitors Nucleopolyhedroviruses Protein Structure Tertiary caspases peptide complex Biochemistry inhibitor of apoptosis Multigene Family biology.protein Biophysics extrinsic pathway Apoproteins SMAC Oligopeptides |
Zdroj: | Acta Crystallographica Section D: Biological Crystallography |
ISSN: | 1399-0047 0907-4449 |
DOI: | 10.1107/s0907444913016284 |
Popis: | The high-resolution crystal structures of apo and peptide-bound XIAP BIR2 are presented and compared with BIR3 structures to understand their selectivity. This crystal system can be used to determine the structures of BIR2–inhibitor complexes. XIAP, a member of the inhibitor of apoptosis family of proteins, is a critical regulator of apoptosis. Inhibition of the BIR domain–caspase interaction is a promising approach towards treating cancer. Previous work has been directed towards inhibiting the BIR3–caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2–caspase-3 interaction would also block the extrinsic pathway. The BIR2 domain of XIAP has successfully been crystallized; peptides and small-molecule inhibitors can be soaked into these crystals, which diffract to high resolution. Here, the BIR2 apo crystal structure and the structures of five BIR2–tetrapeptide complexes are described. The structural flexibility observed on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors. |
Databáze: | OpenAIRE |
Externí odkaz: |